200
Participants
Start Date
April 30, 2003
Study Completion Date
April 30, 2005
zoledronic acid
Staten Island Urological Research, PC, Staten Island
AccuMed Research Associates, Garden City
Urological Surgeons of L.I., Garden City
Triangle Urological Group, Pittsburgh
Urologic Associates of Allentown, Allentown
Albert Einstein Medical Center, Philadelphia
Summitt Clinical Research, Owings Mills
Carolina Urologic Research Center, Myrtle Beach
Atlantic Urological Associates, Daytona Beach
Southeastern Urological Center, PA, Tallahassee
University of Miami School of Medicine, Dept. of Urology, Miami
Urosearch, Ocala
Advanced Research Institute, Inc., New Port Richey
Millennium Therapeutics & Research, Birmingham
Medical Affiliated Research Center, Huntsville
Integrity Clinical Research, LLC, Germantown
Mount Vernon Urological Associates, Mount Vernon
Urological Associates, Inc., Columbus
The Urology Group, Cincinnati
Medisphere Medical Research Center, LLC, Evansville
Millennium Medical Center, Southfield
The Iowa Clinic, PC, Iowa Urology Research, Des Moines
Quality Clinical Research LLC, Springfield
Arkansas Urology, Little Rock
Urology San Antonio Research, San Antonio
Salt Lake Research, Salt Lake City
Advanced Clinical Therapeutics, Tucson
Donald Gleason, MD, Tucson
Western Clinical Research, Torrance
Atlantic Urological Medical Group, Long Beach
San Diego Uro. Research, San Diego
Advanced Urology Med. Center, Anaheim
The Urology Clinic, Portland
Oregon Urology Specialists, Eugene
Seattle Urological Associates, Seattle
Rockwood Clinic, Spokane
Alaska Clinical Research Center, Anchorage
Connecticut Surgical Group, Hartford
Grove Hill Urology, New Britain
Associated Urologic Specialist, PA, Marlton
Morristown Memorial Hospital, Morristown
Associates In Urology, LLC, West Orange
Urologic Surgeons of New England, P.C., Providence
University Urological Research Institute, Providence
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY